Daniel Pallin, MD, MPH - Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy –Related Adverse Effects in the Emergency Department
Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - November 30, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Daniel Pallin, MD, MPH - Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy –Related Adverse Effects in the Emergency Department
Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - November 30, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Upfront Management & Immunotherapy Of All
Pinkal Desai, M.D., Assistant Professor of Medicine<br />Weill Cornell Medical College, Cornell University And Assistant Attending Physician at the New York-Presbyterian Hospital Discusses Upfront Managem...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Upfront Management & amp; Immunotherapy of ALL
Pinkal Desai, M.D., Assistant Professor of Medicine<br />Weill Cornell Medical College, Cornell University And Assistant Attending Physician at the New York-Presbyterian Hospital Discusses Upfront Managem...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy of ALL
Earn CME: <a target='_blank' href='https://naccme.com/program/7310'>https://naccme.com/program/...</a><br /><br />In this presentation from the 'New and Emerging Agents in ALL and the Evolving Treatment Paradigm symposium, Dr. Pinkal Desai discusses the use of immothe...
Author: imedex
Added: 11/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 27, 2018 Category: Cancer & Oncology Source Type: podcasts
Long-Term Management of Patients Doing Well on Immunotherapy for Advanced NSCLC: Insights from KEYNOTE-010 (BMIC-066)
Dr. Jack West reviews longitudinal outcomes for patients on the KEYNOTE-010 trial of pembrolizumab (Keytruda) vs. docetaxel as 2nd line therapy for advanced NSCLC, with helpful new info on those compl...
Author: BeaconMedIC
Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 14, 2018 Category: Cancer & Oncology Source Type: podcasts
Updated Results on PACIFIC Trial: Should we Revise Who Should Receive Consolidation Immunotherapy after Chemo/Radiation? (BMIC-065)
Dr. Jack West discusses the trial design of the PACIFIC trial of consolidation durvalumab (Imfinzi) after chemo/radiation for unresectable stage III NSCLC and highlights new data on overall survival a...
Author: BeaconMedIC
Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts
Beyond Checkpoint Blockade
Charles G. Drake MD / PhD Director GU Medical Oncology Co-Director: Immunotherapy Program Associate Director for Clinical Research Professor of Oncology and Urology Herbert Irving Cancer Center at Col...
Author: kidneycancer
Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy Moving To Frontline
Amishi Y. Shah, MD Assistant Professor Genitourinary Medical Oncology MD Anderson Cancer Center Discusses Immunotherapy Moving To Frontline. At Kidney Cancer Association National Patient and Caregiver...
Author: kidneycancer
Added: 10/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy In Chromophobe RCC
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Immunotherapy In Chromophobe RCC. At Kidney Cancer Association Na...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Combination, TKI, Immunotherapy Efficacy
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Combination, TKI, Immunotherapy Efficacy. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on...
Author: kidneycancer
Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Sequencing Immunotherapies In Kidney Cancer
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Sequencing Immunotherapies In Kidney Cancer. At Kidney Cancer Association Nationa...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
When Should A Patient Receive Immunotherapy?
Matt Campbell MD, MS Assistant Professor Department of Genitourinary Medical Oncology UT MD Anderson Cancer Center Discusses When Should A Patient Receive Immunotherapy? At Kidney Cancer Association N...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy of myeloma: BCMA/SLAMF7 CAR T-cells & BiTEs
Multiple myeloma (MM) is at the forefront of immunotherapeutic developments, including T-cell therapies and bispecific antibodies. Here, our expert panel discuss BCMA and SLAMF7 targeting CAR T-cells,...
Author: VJHemOnc
Added: 09/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 14, 2018 Category: Cancer & Oncology Source Type: podcasts
Success of novel immunotherapies for renal cell carcinoma
At the Genitourinary Cancers Symposium 2018 in San Francisco, CA, recent therapeutic developments for renal cell carcinoma (RCC) were discussed by Jeanny Aragon-Ching, MD, FACP, of Inova Schar Cancer ...
Author: VJOncology
Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts
